Biotech Medics is selling for under 0.0185 as of the 30th of November 2024; that is 23.33 percent increase since the beginning of the trading day. The stock's lowest day price was 0.0185. Biotech Medics has about a 37 percent probability of financial distress in the next few years of operation but had a somewhat ok performance during the last 90 days. Equity ratings for Biotech Medics Ne are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of October 2024 and ending today, the 30th of November 2024. Click here to learn more.
BioTech Medics, Inc. operates as a medical-based holding company. The company was incorporated in 1997 and is based in Southlake, Texas with laser pain centers in Texas, California, New Mexico, and Florida. Biotech Medics is traded on OTC Exchange in the United States. The company has 172.36 M outstanding shares. More on Biotech Medics Ne
Biotech Medics Ne [BMCS] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 870.4 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biotech Medics's market, we take the total number of its shares issued and multiply it by Biotech Medics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biotech Medics Ne conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 172.36 M outstanding shares.
Biotech Medics Ne currently holds about 1.31 K in cash with 0 of positive cash flow from operations.
Check Biotech Medics Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Biotech Medics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Theme Ratings Now
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
When running Biotech Medics' price analysis, check to measure Biotech Medics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotech Medics is operating at the current time. Most of Biotech Medics' value examination focuses on studying past and present price action to predict the probability of Biotech Medics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotech Medics' price. Additionally, you may evaluate how the addition of Biotech Medics to your portfolios can decrease your overall portfolio volatility.